Stifel Initiates Coverage On Immunome with Hold Rating, Announces Price Target of $24

Benzinga · 1d ago
Stifel analyst Dara Azar initiates coverage on Immunome (NASDAQ:IMNM) with a Hold rating and announces Price Target of $24.